These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37710185)

  • 41. Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.
    Abbassi YA; Le Guin C; Bornfeld N; Bechrakis NE; Zeschnigk M; Lohmann DR
    Fam Cancer; 2023 Apr; 22(2):193-202. PubMed ID: 35920959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.
    Baqai U; Purwin TJ; Bechtel N; Chua V; Han A; Hartsough EJ; Kuznetsoff JN; Harbour JW; Aplin AE
    Mol Cancer Res; 2022 Aug; 20(8):1260-1271. PubMed ID: 35426938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Piloting a Deep Learning Model for Predicting Nuclear BAP1 Immunohistochemical Expression of Uveal Melanoma from Hematoxylin-and-Eosin Sections.
    Zhang H; Kalirai H; Acha-Sagredo A; Yang X; Zheng Y; Coupland SE
    Transl Vis Sci Technol; 2020 Sep; 9(2):50. PubMed ID: 32953248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
    Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
    Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BAP1 loss augments sensitivity to BET inhibitors in cancer cells.
    Xu YY; Ren ZL; Liu XL; Zhang GM; Huang SS; Shi WH; Ye LX; Luo X; Liu SW; Li YL; Yu L
    Acta Pharmacol Sin; 2022 Jul; 43(7):1803-1815. PubMed ID: 34737422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas.
    Han LM; Lee KW; Uludag G; Seider MI; Afshar AR; Bloomer MM; Pekmezci M
    Mod Pathol; 2023 Apr; 36(4):100081. PubMed ID: 36788079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
    Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
    Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
    Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
    Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin Receptor Expression in Primary Uveal Melanoma.
    Hagström A; Kal Omar R; Witzenhausen H; Lardner E; Abdiu O; Stålhammar G
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Punctuated evolution of canonical genomic aberrations in uveal melanoma.
    Field MG; Durante MA; Anbunathan H; Cai LZ; Decatur CL; Bowcock AM; Kurtenbach S; Harbour JW
    Nat Commun; 2018 Jan; 9(1):116. PubMed ID: 29317634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
    Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
    Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M; Talarchek J; Schindeler K; Saraiva E; Penney LS; Ludman M; Testa JR
    Cancer Genet; 2013 May; 206(5):206-10. PubMed ID: 23849051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
    Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncologist-led germline genetic testing for uveal melanoma.
    Gillies B; Krema H; Chao A; Lando L; Farncombe KM; Butler M; Altomare F; Kim RH
    Ophthalmic Genet; 2023 Jun; 44(3):253-261. PubMed ID: 36974392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
    Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
    BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimation of the timing of BAP1 mutation in uveal melanoma progression.
    Uner OE; See TRO; Szalai E; Grossniklaus HE; Stålhammar G
    Sci Rep; 2021 Apr; 11(1):8923. PubMed ID: 33903674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity.
    Ma S; Huis In't Veld RV; Houy A; Stern MH; Rich C; Ossendorp FA; Jager MJ
    Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):10. PubMed ID: 37272766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.